Chinese General Practice ›› 2019, Vol. 22 ›› Issue (22): 2755-2759.DOI: 10.12114/j.issn.1007-9572.2019.00.420
Special Issue: 泌尿系统疾病最新文章合集
• Monographic Research • Previous Articles Next Articles
Published:
2019-08-05
Online:
2019-08-05
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.420
[1]LEVIN A,STEVENS P E,BILOUS R W,et al.Kidney Disease Improving Global Outcomes(KDIGO) CKD Work Group.KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J].Kidney International Supplements,2013,3(1):1-150. [2]BELLO A K,LEVIN A,TONELLI M,et al.Assessment of global kidney health care status[J].JAMA,2017,317(18):1864-1881.DOI:10.1001/jama.2017.4046. [3]MILLS K T,XU Y,ZHANG W D,et al.A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010[J].Kidney Int,2015,88(5):950-957.DOI:10.1038/ki.2015.230. [4]MATHEW T,CORSO O.Review article:early detection of chronic kidney disease in Australia:which way to go[J].Nephrology(Carlton),2009,14(4):367-373.DOI:10.1111/j.1440-1797.2009.01113.x. [5]郑法雷.慢性肾脏疾病筛查的必要性和实施方法[J].诊断学理论与实践,2007,6(6):475-477.DOI:10.3969/j.issn.1671-2870.2007.06.001. ZHENG F L.Necessity and implement methods of screening chronic kidney disease[J].Journal of Diagnostics Concepts & Practice,2007,6(6):475-477.DOI:10.3969/j.issn.1671-2870.2007.06.001. [6]JHA V,GARCIA-GARCIA G,ISEKI K,et al.Chronic kidney disease:global dimension and perspectives[J].Lancet,2013,382(9888):260-272.DOI:10.1016/S0140-6736(13)60687-X. [7]GOLESTANEH L,ALVAREZ P J,REAVEN N L,et al.All-cause costs increase exponentially with increased chronic kidney disease stage[J].Am J Manag Care,2017,23(10 suppl):s163-172. [8]JOMMI C,ARMENI P,BATTISTA M,et al.The cost of patients with chronic kidney failure before dialysis:results from OST of patients with chronic kidney failure before dialysis:results from the IRIDE observational study[J].Pharmacoecon Open,2018,2(4):459-467.DOI:10.1007/s41669-017-0062-z. [9]ZHANG L,WANG F,WANG L,et al.Prevalence of chronic kidney disease in China:across-sectional survey[J].The Lancet,2012,379(9818):815-822.DOI:10.1016/S0140-6736(12)60033-6. [10]GALBRAITH L,HEMMELGARN B,MANNS B,et al.The association between individual counselling and health behaviour change:the See Kidney Disease(SeeKD) targeted screening programme for chronic kidney disease[J].Can J Kidney Health Dis,2016,3:35.DOI:10.1186/s40697-016-0127-4. [11]ZHANG L X,LONG J Y,JIANG W S,et al.Trends in chronic kidney disease in China[J].N Engl J Med,2016,375(9):905-906.DOI:10.1056/NEJMc1602469. [12]JOHNSON D W.Evidence-based guide to slowing the progression of early renal in sufficiency[J].Internal Medicine Journal,2004:50-57.DOI:10.1111/j.1444-0903.2004.t01-6-x. [13]VAN DER VELDE M,HALBESMA N,DE CHARRO F T,et al.Screening for albuminuria identifies individuals at increased renal risk[J].J Am Soc Nephrol,2009,20(4):852-862.DOI:10.1681/ASN.2008060655. [14]QASEEM A,HOPKINS R H,SWEET D E,et al.Screening,monitoring,and treatment of stage 1 to 3 chronic kidney disease:a clinical practice guideline from the American College of Physicians[J].Ann Intern Med,2013,159(12):835-847.DOI:10.7326/0003-4819-159-12-201312170-00726. [15]LAVALLEE B,CHARTRAND C,MCLEOD L,et al.Mass screening for chronic kidney disease in rural and remote Canadian first nations people:methodology and demographic characteristics[J].Canadian Journal of Kidney Health and Disease,2015,2(1):1-10.DOI:10.1186/s40697-015-0046-9. [16]上海慢性肾脏病早发现及规范化诊治与示范项目专家组.慢性肾脏病筛查诊断及防治指南[J].中国实用内科杂志,2017,37(1):28-34.DOI:10.19538/j.nk2017010108. Expert Group on Early Detection,Diagnosis and Treatment System Construction of Chronic Kidney Disease in Shanghai.Guideline for screening,diagnosis,prevention and treatment of chronic kidney disease[J].Chinese Journal of Practical Internal Medicine,2017,37(1):28-34.DOI:10.19538/j.nk2017010108. [17]GO D S,KIM S H,PARK J,et al.Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea[J].Nephrology(Carlton),2019,24(1):56-64.DOI:10.1111/nep.13203. [18]KOMENDA P,FERGUSON T W,MACDONALD K,et al.Cost-effectiveness of primary screening for CKD:a systematic review[J].Am J Kidney Dis,2014,63(5):789-797.DOI:10.1053/j.ajkd.2013.12.012. [19]MANNS B,HEMMELGARN B,TONELLI M,et al.Population based screening for chronic kidney disease:cost effectiveness study[J].BMJ,2010,341:c5869.DOI:10.1136/bmj.c5869. [20]JOHNSON D W,ATAI E,CHAN M,et al.KHA-CARI guideline:early chronic kidney disease:detection,prevention and management[J].Nephrology,2013,18(5):340-350.DOI:10.1111/nep.12052. [21]National Clinical Guideline Centre(UK).Chronic kidney disease(partial update):early identification and management of chronic kidney disease in adults in primary and secondary care [EB/OL].[2019-01-10].https://www.nice.org.uk/. [22]Ministry of Health.Chronic kidney disease:identification,evaluation and management of adult patients[EB/OL].[2019-01-10].https://www2.gov.bc.ca/assets/gov/health/practitioner-pro/bc-guidelines/ckd-full-guideline.pdf. [23]Ministry of Health.Managing chronic kidney disease in primary care:national consensus statement[EB/OL].[2019-01-10].https://www.health.govt.nz/system/files/documents/publications/managing-chronic-kidney-disease-primary-care-mar15-v2.pdf. [24]GEORGE C,MOGUEO A,OKPECHI I,et al.Chronic kidney disease in low-income to middle-income countries:the case for increased screening[J].BMJ Glob Health,2017,2(2):e000256.DOI:10.1136/bmjgh-2016-000256. [25]FLOOD D,GARCIA P,DOUGLAS K,et al.Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala:a cross-sectional study[J].BMJ Open,2018,8(1):e019778.DOI:10.1136/bmjopen-2017-019778. [26]GHEEWALA P A,ZAIDI S T R,JOSE M D,et al.Effectiveness of targeted screening for chronic kidney disease in the community setting:a systematic review[J].J Nephrol,2018,31(1):27-36.DOI:10.1007/s40620-017-0375-0. [27]HOWARD K,SALKELD G,WHITE S L,et al.Thecost-effectiveness of early detection and intervention to prevent the progression of chronic kidney disease in Australia[M].Melbourne:Kidney Health Australia,2006. [28]OLMOS R D.Screening for chronic kidney disease and inequity[J].Sao Paulo Med J,2016.DOI:10.1590/1516-3180.2016.0082080516. [29]BOCHUD M.On the rationale of population screening for chronic kidney disease:a public health perspective[J].Public Health Rev,2015,36:11.DOI:10.1186/s40985-015-0009-9. [30]MOYER V A.Screening for chronic kidney disease:US preventive services task force recommendation statement[J].Ann Intern Med,2012,157(8):567-570.DOI:10.7326/0003-4819-157-8-201210160-00533. [31]潘玉静,张路霞.估算肾小球滤过率的评价方法[J].中华内科杂志,2016,55(3):237-240.DOI:10.3760/cma.j.issn.0578-1426.2016.03.019. PAN Y J,ZHANG L X.Evaluation method for estimating glomerular filtration rate[J].Chinese Journal of Internal Medicine,2016,55(3):237-240.DOI:10.3760/cma.j.issn.0578-1426.2016.03.019. [32]KLAHR S,LEVEY A S,BECK G J,et al.The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease.Modification of Diet in Renal Disease Study Group[J].N Engl J Med,1994,330(13):877-884.DOI:10.1056/NEJM199403313301301. [33]RATNAYAKE S,BADURDEEN Z,NANAYAKKARA N,et al.Screening for chronic kidney disease of uncertain aetiology in Sri Lanka:usability of surrogate biomarkers over dipstick proteinuria[J].BMC Nephrol,2017,18(1):199.DOI:10.1186/s12882-017-0610-x. [34]PEREZMONTEOLIVA N R,FELIX F J,LOZANO L,et al.The HUGE formula(hematocrit,urea,sex) for screening chronic kidney disease(CKD) in an age-stratified general population[J].Journal of Nutrition Health & Aging,2015,19(6):688-692.DOI:10.1007/s12603-015-0504-1. [35]PHAM T A.Validation of the salivary urea and creatinine tests as screening methods of chronic kidney disease in Vietnamese patients[J].Acta Odontol Scand,2017,75(8):551-556.DOI:10.1080/00016357.2017.1356467. [36]MAO F,LIU S Y,QIAO X N,et al.Sudoscan,an effective tool for screening chronic kidney disease in patients with type 2 diabetes[J].Exp Ther Med,2017,14(2):1343-1350.DOI:10.3892/etm.2017.4689. [37]SAXENA A,GUPTA A,ABRAHAM G,et al.Non-invasive screening tool for chronic kidney disease[J].Saudi J Kidney Dis Transpl,2015,26(6):1311-1313.DOI:10.4103/1319-2442.168697. [38]WANG H Y,YANG L,WANG F,et al.Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease[J].BMC Nephrol,2017,18(1):135.DOI:10.1186/s12882-017-0538-1. [39]BANG H,MAZUMDAR M,NEWMAN G,et al.Screening for kidney disease in vascular patients:Screening for Occult Renal Disease(SCORED) experience[J].Nephrol Dial Transplant,2009,24(8):2452-2457.DOI:10.1093/ndt/gfp124. [40]ASHTON C W,DUFFIE D.Chronic kidney disease in Canada's First Nations:results of an effective cross-cultural collaboration[J].Healthc Q,2011,14(3):42-47. [41]CURTIS C,BALINT C,AL HAMARNEH Y N,et al.Online clinical pathway for managing adults with chronic kidney disease[J].Can Pharm J(Ott),2015,148(5):257-262.DOI:10.1177/1715163515597243. [42]SAMAL L,D'AMORE J D,BATES D W,et al.Implementation of a scalable,web-based,automated clinical decision support risk-prediction tool for chronic kidney disease using C-CDA and application programming interfaces[J].J Am Med Inform Assoc,2017,24(6):1111-1115.DOI:10.1093/jamia/ocx065. [43]PERALTA C A,FRIGAARD M,RUBINSKY A D,et al.Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans[J].BMC Nephrol,2017,18(1):132.DOI:10.1186/s12882-017-0541-6. [44]WONG D,CAO S,FORD H,et al.Exploring the use of tablet computer-based electronic data capture system to assess patient reported measures among patients with chronic kidney disease:a pilot study[J].BMC Nephrol,2017,18(1):356.DOI:10.1186/s12882-017-0771-7. [45]牛娜,董建琴,杜雪平.北京市基层全科医生对慢性肾脏病的认知调查[J].中国全科医学,2017,20(10):1267-1270.DOI:10.3969/j.issn.1007-9572.2017.10.025. NIU N,DONG J Q,DU X P.Cognition of grass-roots general practitioners on chronic kidney disease in Beijing[J].Chinese General Practice,2017,20(10):1267-1270.DOI:10.3969/j.issn.1007-9572.2017.10.025. [46]GEORGE P P,OH C M,LOH P T,et al.Right-siting chronic kidney disease care-a survey of general practitioners in Singapore[J].Ann Acad Med Singap,2013,42(12):646-656. [47]TONKIN-CRINE S,SANTER M,LEYDON G M,et al.GPs' views on managing advanced chronic kidney disease in primary care:a qualitative study[J].Br J Gen Pract,2015,65(636):e469-477.DOI:10.3399/bjgp15X685693. |
[1] | ZHANG Hanzhi, GE Xuhua, LU Yuan, JIN Hua, GUO Aizhen, CHEN Yuge, MA Linlin, PAN Ying, YU Dehua. Exploration and Differential Analysis of Continuing Education of General Practitioners' Clinical Thinking Ability Based on Working Competence [J]. Chinese General Practice, 2023, 26(34): 4315-4321. |
[2] | YAO Yuzhong, MA Xiaojun, SONG Huan, ZHONG Yu. The Management Effect of Diabetes "1358 model" on Community Diabetes Patients Based on "Precision Management Combining General Care and Specialty Care" [J]. Chinese General Practice, 2023, 26(34): 4308-4314. |
[3] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[4] | HAO Aihua, ZENG Weilin, LI Guanhai, XIA Yinghua, CHEN Liang. Current Situation of the Construction of Family Doctor Team: an Investigation Based on the Perspective of General Practitioners [J]. Chinese General Practice, 2023, 26(34): 4261-4268. |
[5] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[6] | HUANG Jinling, ZENG Zhirong. The Logic and Trend of Urban Community Health Service Policies in China [J]. Chinese General Practice, 2023, 26(34): 4239-4245. |
[7] | YANG Hui, HU Ruwei, LIU Ruqing, LU Junfeng, WU Jinglan. Relationship between Community Health Service Experience and Glycemic Control Outcomes in Patients with Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(34): 4290-4295. |
[8] | XU Jian, DAI Fangfang, PAN Wenlei, HUANG Qian, LU Ping, WANG Jianfeng, JIA Huan, YANG Yuqi, HUANG Jiaoling. Visual Analysis of Hotspots and Cutting-edge Trends of Community TCM Service Research in China in the Context of Healthy China [J]. Chinese General Practice, 2023, 26(34): 4343-4350. |
[9] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[10] | YIN Zhaoxia, MAO Lidong, ZHANG Baoshuang, HUANG Yin, FENG Yang, WANG Yunfei. Spectrum of Outpatient Illnesses in Children Contracting Family Doctor Services in Shenzhen's Community Settings and Related Implications for Standardized Residency Training of General Practitioners [J]. Chinese General Practice, 2023, 26(33): 4218-4224. |
[11] | ZHANG Peng, GAO Ying, YANG Hongxi, WAN Chunxiao. Association between Serum Uric Acid Level and the Risk of Chronic Kidney Disease among the Elderly in Longevity Areas of China [J]. Chinese General Practice, 2023, 26(31): 3884-3889. |
[12] | YU Dehua. Scientific Research Conception Guided by General Practice Thinking [J]. Chinese General Practice, 2023, 26(31): 3872-3876. |
[13] | HONG Yuchun, WU Hua, DU Yishan, LI Shuran, SUN Wenmin, YE Mingyu, ZHANG Yongjian, LI Yang. Development of General Practice Diagnostic Terminology and Coding and Empirical Study on Its Application [J]. Chinese General Practice, 2023, 26(31): 3896-3901. |
[14] | ZHOU Yingda, ZHUO Shuxiong, YANG Xi, JIN Hua, YU Dehua. Implementation Status and Strategy Research on the Construction of Clinical Pathways for Diagnosis and Treatment of Medically Unexplained Disease in Community General Practice [J]. Chinese General Practice, 2023, 26(31): 3939-3944. |
[15] | ZHOU Dongdong, GE Xuhua. The Evaluation Index of Post Competence of General Practitioners in Less-developed Areas [J]. Chinese General Practice, 2023, 26(31): 3908-3914. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||